Comparing Ampyra vs Aubagio
Ampyra (dalfampridine) | Aubagio (teriflunomide) |
|
---|
Ampyra (dalfampridine) | Aubagio (teriflunomide) |
|
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Multiple Sclerosis. Ampyra may also be used for purposes not listed in this medication guide. |
Prescription only
Aubagio is a selective immunosuppressant that may be used in the treatment of multiple sclerosis. It interacts with many other medications and carries a boxed warning about the risk of liver toxicity... View more |
Related suggestions Popular comparisons
|
|||||||||||||||
More about Ampyra (dalfampridine) | More about Aubagio (teriflunomide) | ||||||||||||||||
Ratings & Reviews | |||||||||||||||||
Ampyra has an average rating of 8.0 out of 10 from a total of 77 ratings on Drugs.com. 73% of reviewers reported a positive effect, while 13% reported a negative effect. |
Aubagio has an average rating of 5.3 out of 10 from a total of 86 ratings on Drugs.com. 37% of reviewers reported a positive effect, while 38% reported a negative effect. |
||||||||||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
View all Ampyra side effects |
View all Aubagio side effects |
||||||||||||||||
Drug Class | |||||||||||||||||
Generic Availability | |||||||||||||||||
Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Ampyra prices |
View all Aubagio prices |
||||||||||||||||
Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
Brand Names | |||||||||||||||||
N/A |
N/A |
||||||||||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
6.5 hours |
456 hours |
||||||||||||||||
CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
Pregnancy Category | |||||||||||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
||||||||||||||||
Drug Interactions | |||||||||||||||||
A total of 51 drugs are known to interact with Ampyra:
|
A total of 744 drugs are known to interact with Aubagio:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
||||||||||||||||
Disease Interactions | |||||||||||||||||
First Approval Date | |||||||||||||||||
January 22, 2010 |
September 12, 2012 |
||||||||||||||||
WADA Class View classifications | |||||||||||||||||
N/A |
N/A |
||||||||||||||||
More Information | |||||||||||||||||
Patient Resources | |||||||||||||||||
Professional Resources | |||||||||||||||||
Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.